5 Policy Asks to Optimize Cross-border Patient Access to Transformative Therapies
The TRANSFORM MEP Interest Group launched 5 Policy Asks on how to optimize cross-border patient access to transformative therapies at their online event on 10 November 2021.
TRANSFORM: Multi-stakeholder approach to gene and cell therapies
TRANSFORM is a multi-stakeholder alliance composed of patient groups, medical experts and associations, healthcare and non-healthcare specialists, scientists, researchers, industry actors and other relevant stakeholders. We advocate for improving the regulatory and legislative systems with the intention to realise the promise of transformative therapies to cure severe, disabling or life-limiting conditions.
High-level meeting of the TRANSFORM MEP Interest Group
On 30 June, join the European Alliance for Transformative Therapies for the launch of its Recommendations for Action for Cell and Gene Therapies in the context of the European Pharmaceutical Strategy which have been developed collaboratively with expert stakeholders.